Literature DB >> 28881079

Formyl Peptide Receptors in Mice and Men: Similarities and Differences in Recognition of Conventional Ligands and Modulating Lipopeptides.

Malene Winther1, Claes Dahlgren1, Huamei Forsman1.   

Abstract

The pattern recognition formyl peptide receptors (FPRs) belong to the class of G-protein-coupled receptors (GPCRs), the largest group of cell surface receptors involved in a range of physiological processes and pathologies. The FPRs have regulatory function in the initiation as well as resolution of inflammatory reactions, making them highly interesting as targets for drug development. Recent research in the GPCR/FPR fields has uncovered novel receptor biology concepts, including biased signalling/functional selectivity, allosteric modulation, receptor reactivation and receptor cross-talk. When it comes to allosteric modulators, 'tailor-made' lipopeptides (pepducins and lipopeptoids) represent a novel concept of GPCR/FPR regulation. This MiniReview is focused on the basis for recognition of conventional ligands and immunomodulating lipopeptides, novel allosteric modulators for the FPRs, receptors that are highly expressed by both human and mouse neutrophils. The FPRs play key roles in host defence against microbial infections, tissue homeostasis and the initiation as well as resolution of inflammation but there are both similarities and differences in ligand recognition between mice and men. Thus, identification and functional characterization of activating and inhibiting ligands should provide insights into future design of FPR-based animal models of human diseases and development of therapeutics for treating inflammatory diseases.
© 2017 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28881079     DOI: 10.1111/bcpt.12903

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  8 in total

Review 1.  Neutrophil Signaling That Challenges Dogmata of G Protein-Coupled Receptor Regulated Functions.

Authors:  Claes Dahlgren; André Holdfeldt; Simon Lind; Jonas Mårtensson; Michael Gabl; Lena Björkman; Martina Sundqvist; Huamei Forsman
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-11

Review 2.  Unraveling neutrophil- Yersinia interactions during tissue infection.

Authors:  Joan Mecsas
Journal:  F1000Res       Date:  2019-07-11

3.  FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis.

Authors:  Jack Leslie; Ben Jm Millar; Alicia Del Carpio Pons; Rachel A Burgoyne; Joseph D Frost; Ben S Barksby; Saimir Luli; Jon Scott; A John Simpson; Jack Gauldie; Lynne A Murray; Donna K Finch; Alan M Carruthers; John Ferguson; Matthew A Sleeman; David Rider; Rachel Howarth; Christopher Fox; Fiona Oakley; Andrew J Fisher; Derek A Mann; Lee A Borthwick
Journal:  JCI Insight       Date:  2020-02-27

Review 4.  Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?

Authors:  Nils Helge Schebb; Hartmut Kühn; Astrid S Kahnt; Katharina M Rund; Valerie B O'Donnell; Nicolas Flamand; Marc Peters-Golden; Per-Johan Jakobsson; Karsten H Weylandt; Nadine Rohwer; Robert C Murphy; Gerd Geisslinger; Garret A FitzGerald; Julien Hanson; Claes Dahlgren; Mohamad Wessam Alnouri; Stefan Offermanns; Dieter Steinhilber
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

5.  Bam32/DAPP1-Dependent Neutrophil Reactive Oxygen Species in WKYMVm-Induced Microvascular Hyperpermeability.

Authors:  Li Hao; Aaron J Marshall; Lixin Liu
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

Review 6.  Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform.

Authors:  Sara Rezzola; Alessandra Loda; Michela Corsini; Francesco Semeraro; Tiziana Annese; Marco Presta; Domenico Ribatti
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

7.  In vivo Anti-inflammatory Activity of Lipidated Peptidomimetics Pam-(Lys-βNspe)6-NH2 and Lau-(Lys-βNspe)6-NH2 Against PMA-Induced Acute Inflammation.

Authors:  Bing C Wu; Sarah L Skovbakke; Hamid Masoudi; Robert E W Hancock; Henrik Franzyk
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

8.  Effects of Formyl Peptide Receptor Agonists Ac9-12 and WKYMV in In Vivo and In Vitro Acute Inflammatory Experimental Models.

Authors:  Izabella Lice; José Marcos Sanches; Rebeca D Correia-Silva; Mab P Corrêa; Marcelo Y Icimoto; Alex A R Silva; Salvador Sánchez-Vinces; Andreia M Porcari; Vanessa Moreira; Cristiane D Gil
Journal:  Cells       Date:  2022-01-11       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.